Physician profile
Eric J Mancini
NPI 1487941910
$14,851.71
in general payments reported to CMS, 2019-2025
13 companies · $2,935 in 2025
The $2,935 reported for 2025 was more than what 76% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $705 · 2020: $1,615 · 2021: $2,386 · 2022: $3,189 · 2023: $1,558 · 2024: $2,464 · 2025: $2,935.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,767 · Food and Beverage: $2,190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,766.92 |
| Food and Beverage | $2,190.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $9,715.51 | 2020-2025 | |
| Medwest Associates | $2,242.81 | 2019-2022 | |
| Stryker Corporation | $1,716.86 | 2019-2025 | Aequalis Flex Revive, Blueprint Patient Specific Instrumentation, Aequalis Perform Reversed |
| Alphatec Spine, INC | $288.73 | 2022 | |
| Zak Ortho | $275.87 | 2025 | |
| Wright Medical Technology, INC. | $137.56 | 2019 | |
| Novus Surgical Consultants | $135.29 | 2023 | |
| Pinnacle, INC | $118.89 | 2025 | |
| Ferring Pharmaceuticals INC. | $75.39 | 2019-2022 | |
| Si-Bone, INC. | $70.63 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $39.92 | 2022 | |
| Bioventus LLC | $22.44 | 2022 | |
| Depuy Synthes Sales INC. | $11.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Mancini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.